|
DE3779221D1
(de)
|
1986-08-19 |
1992-06-25 |
Genentech Inc |
Einrichtung und dispersion zum intrapulmonalen eingeben von polypeptidwuchsstoffen und -zytokinen.
|
|
JPH01215289A
(ja)
|
1988-02-22 |
1989-08-29 |
Toa Nenryo Kogyo Kk |
遺伝子組換えによる正常ヒト血清アルブミンａの製造方法
|
|
FR2649991B2
(fr)
|
1988-08-05 |
1994-03-04 |
Rhone Poulenc Sante |
Utilisation de derives stables du plasmide pkd1 pour l'expression et la secretion de proteines heterologues dans les levures du genre kluyveromyces
|
|
US5728553A
(en)
|
1992-09-23 |
1998-03-17 |
Delta Biotechnology Limited |
High purity albumin and method of producing
|
|
JPH10500672A
(ja)
|
1994-05-18 |
1998-01-20 |
インヘイル セラピューティック システムズ，インコーポレイティド |
インターフェロンの乾燥粉末製剤に関する方法及び組成物
|
|
DE4417598A1
(de)
|
1994-05-19 |
1995-12-14 |
Max Planck Gesellschaft |
Verwendung des Tetracyclinpromotors zur stringent regulierten Produktion von rekombinanten Proteinen in prokaryontischen Zellen
|
|
AU5132096A
(en)
|
1995-01-30 |
1996-08-21 |
Terrapin Technologies, Inc. |
Glubodies - multiplicities of proteins capable of binding a variety of small molecules
|
|
US5908621A
(en)
|
1995-11-02 |
1999-06-01 |
Schering Corporation |
Polyethylene glycol modified interferon therapy
|
|
US6620413B1
(en)
|
1995-12-27 |
2003-09-16 |
Genentech, Inc. |
OB protein-polymer chimeras
|
|
DE19641876B4
(de)
|
1996-10-10 |
2011-09-29 |
Iba Gmbh |
Streptavidinmuteine
|
|
WO1998016873A1
(en)
|
1996-10-14 |
1998-04-23 |
Firm Forsat Ltd. |
Method for preparing dispersions of chromogenic components
|
|
DE19742706B4
(de)
|
1997-09-26 |
2013-07-25 |
Pieris Proteolab Ag |
Lipocalinmuteine
|
|
GB9722131D0
(en)
|
1997-10-20 |
1997-12-17 |
Medical Res Council |
Method
|
|
CA2233725A1
(en)
|
1998-03-31 |
1999-09-30 |
Hemosol Inc. |
Hemoglobin-hydroxyethyl starch complexes
|
|
HRP20000808A2
(en)
|
1998-06-08 |
2001-10-31 |
Hoffmann La Roche |
Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis c
|
|
US6403564B1
(en)
|
1998-10-16 |
2002-06-11 |
Schering Corporation |
Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
|
|
DE19926068C1
(de)
|
1999-06-08 |
2001-01-11 |
Arne Skerra |
Muteine des Bilin-Bindungsproteins
|
|
US7235520B2
(en)
|
2000-09-21 |
2007-06-26 |
University Of Massachusetts |
Method of inducing apoptosis in lymphoid cells
|
|
EP1377306A1
(en)
|
2001-03-09 |
2004-01-07 |
Dyax Corp. |
Serum albumin binding moieties
|
|
WO2003029462A1
(en)
|
2001-09-27 |
2003-04-10 |
Pieris Proteolab Ag |
Muteins of human neutrophil gelatinase-associated lipocalin and related proteins
|
|
AU2001298053A1
(en)
|
2001-09-27 |
2003-04-14 |
Pieris Proteolab Ag |
Muteins of apolipoprotein D
|
|
EP1658308A1
(en)
|
2003-08-25 |
2006-05-24 |
Pieris ProteoLab AG |
Muteins of a bilin-binding protein with affinity for a given target
|
|
AU2003275958A1
(en)
|
2003-08-25 |
2005-03-10 |
Pieris Proteolab Ag |
Muteins of tear lipocalin
|
|
JP2007284351A
(ja)
|
2004-07-27 |
2007-11-01 |
Osaka Bioscience Institute |
アミロイド蛋白質の凝集を抑制する物質とその作用
|
|
EP2899277A1
(en)
|
2004-11-26 |
2015-07-29 |
Pieris AG |
Compound with affinity for the cytotoxic T lymphocyte-associated antigen (CTLA-4)
|
|
EP1923463B1
(en)
*
|
2005-08-09 |
2011-10-05 |
Oncotherapy Science, Inc. |
Cancer-rejection antigen peptide derived from glypican-3 (gpc3) for use in hla-a2-positive patient and pharmaceutical comprising the antigen
|
|
WO2007038619A2
(en)
|
2005-09-27 |
2007-04-05 |
Amunix, Inc. |
Proteinaceous pharmaceuticals and uses thereof
|
|
US20070087005A1
(en)
|
2005-10-14 |
2007-04-19 |
Lazar Gregory A |
Anti-glypican-3 antibody
|
|
US8598317B2
(en)
*
|
2006-03-20 |
2013-12-03 |
Technische Universitaet Muenchen |
Muteins of tear lipocalin with affinity for the T-cell coreceptor CD4
|
|
WO2007137170A2
(en)
|
2006-05-20 |
2007-11-29 |
Seattle Genetics, Inc. |
Anti-glypican-3 antibody drug conjugates
|
|
DK2046820T3
(da)
|
2006-08-01 |
2011-02-07 |
Pieris Ag |
Muteiner af tåre-lipocalin og fremgangsmåder til opnåelse deraf
|
|
CN101815726B
(zh)
|
2007-07-17 |
2013-04-03 |
米德列斯公司 |
针对磷脂酰肌醇蛋白聚糖-3的单克隆抗体
|
|
WO2009052392A1
(en)
|
2007-10-19 |
2009-04-23 |
Abbott Laboratories |
Immunoassays and kits for the detection of ngal
|
|
CA2729322C
(en)
|
2008-06-24 |
2020-05-26 |
Technische Universitaet Muenchen |
Muteins of hngal and related proteins with affinity for a given target
|
|
RU2564125C2
(ru)
|
2009-12-07 |
2015-09-27 |
Пирис Аг |
Мутеины липокалина 2 человека (lcn2, hngal) с аффинностью для определенной мишени
|
|
ES2667066T3
(es)
|
2010-05-24 |
2018-05-09 |
The Trustees Of Columbia University In The City Of New York |
Proteínas NGAL mutantes y usos de las mismas
|
|
CN111499725A
(zh)
|
2010-06-08 |
2020-08-07 |
皮里斯制药有限公司 |
结合IL-4受体α的泪脂质运载蛋白突变蛋白
|
|
DK2606061T3
(da)
|
2010-08-16 |
2017-11-06 |
Pieris Pharmaceuticals Gmbh |
Bindingsproteiner til hepcidin
|
|
US9260492B2
(en)
|
2010-11-15 |
2016-02-16 |
Pieris Ag |
Muteins of human lipocalin 2 with affinity for glypican-3 (GPC-3)
|
|
US20130225505A1
(en)
|
2011-11-23 |
2013-08-29 |
Allergan, Inc. |
Muteins of human tear lipcalin for treating neovascular disease of the anterior segment of the human eye
|
|
WO2013174783A1
(en)
|
2012-05-23 |
2013-11-28 |
Pieris Ag |
Lipocalin muteins with binding-affinity for glypican-3 (gpc-3) and use of lipocalin muteins for target-specific delivery to cells expressing gpc-3
|
|
CA2891557A1
(en)
*
|
2013-03-26 |
2014-05-22 |
Pieris Ag |
Novel specific-binding polypeptides and uses thereof
|
|
CA2973640A1
(en)
|
2015-01-28 |
2016-08-04 |
Rachida Siham Bel Aiba |
Novel proteins specific for angiogenesis
|
|
WO2016131804A1
(en)
|
2015-02-18 |
2016-08-25 |
Sanofi |
Novel proteins specific for pyoverdine and pyochelin
|
|
EP4177262A1
(en)
|
2015-05-04 |
2023-05-10 |
Pieris Pharmaceuticals GmbH |
Proteins specific for cd137
|
|
RU2756318C2
(ru)
|
2015-05-18 |
2021-09-29 |
ПИЕРИС ФАРМАСЬЮТИКАЛС ГмбХ |
Мутеины липокалина 2 человека с аффинностью в отношении глипикана-3 (gpc3)
|